跳至主要内容
临床试验/NCT07028294
NCT07028294已完成不适用

Effectiveness and Clinical Application of Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenic Older Adults With Metabolic Syndrome: Multicenter Empirical Study

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年9月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
5-times chair stand test

研究概览

简要总结

This is an empirical study, which aims to examine the effect of a 12-week combined exercise-nutrition intervention in older adults with sarcopenia and to provide data for clinical and policy decision-making of sarcopenia. The study conducts the combined exercise-nutrition intervention that was previously carried out as a randomized controlled trial. Hand grip strength, gait speed, knee extensor muscle power, physical performance, muscle mass using DEXA, quality of life, activities of daily living, sarcopenia screening questionnaire, nutritional assessment will be evaluated on baseline, 12-weeks and 24-weeks after intervention.

详细描述

The definition of sarcopenia is age-related loss of skeletal muscle and physical functions. Sarcopenia is emerging health problem and increases medical expenditure as the population ages. Sarcopenia is closely related to chronic diseases and geriatric diseases. In particular, patients with metabolic syndrome showed a high prevalence of muscle loss and muscle weakness. It has been reported exercise in sarcopenia patients not only improved insulin sensitivity and physical performance but also helped the treatment of the diseases. Also, it has recently demonstrated that combined exercise-nutrition intervention improved muscle function in elderly patients. However, the standard protocol for the combined exercise-nutrition intervention has not been established yet. Therefore, this study aims to see the effects of a 12-week combined exercise-nutrition intervention in sarcopenia patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients older than 65 years and under 90 years
  • •patients who meet the criteria for the Asian Working Group for Sarcopenia (AWGS) 2019
  • •patients who had metabolic syndrome

排除标准

  • •patients with less than estimated glomerular filtration rate (eGFR) 30
  • •patients with musculoskeletal or chronic lung disease incapable of exercise
  • •patients with untreated or uncontrolled cardiovascular disease which may affect muscle mass or performing exercise
  • •patients less than 5 years after treatment of malignant tumor
  • •patients with liver cirrhosis, diabetes and other chronic disease
  • •patients who cannot perform combined exercise nutrition intervention for other reasons

研究组 & 干预措施

Combined exercise and nutrition intervention

Experimental

Customized exercise and nutrition intervention by underlying disease and functional state for 12 weeks during intervention period.

干预措施: Combined exercise and nutrition intervention (Combination Product)

结局指标

主要结局

5-times chair stand test

时间窗: Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3)

Change from baseline 5-times chair stand test to 12 weeks after assessment, measured by 5-times chair stand test

次要结局

  • Physical performance(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Gait speed test(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Appendicular skeletal muscle mass(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Health Related Quality of Life(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Basic and instrumental activities of daily living(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Sarcopenia screening questionnaire(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Nutritional Assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Handgrip strength(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Delirium assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Physical acitivity assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Cognitive assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Psychiatric state(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Swallowing assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))
  • Empowerment assessment(Screening (visit 0), Baseline (visit 1), 12 weeks after intervention (visit 2), 24 weeks after intervention (visit 3))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae-Young Lim

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验